Eculizumab as Primary Therapy for Active Antibody-Mediated Rejection of Renal Allografts: A Matter of Timing, Severity, and Donor-Specific Antibodies.
Sign Up to like & getrecommendations! Published in 2019 at "Transplantation"
DOI: 10.1097/tp.0000000000002640
Abstract: D increased utilization of paired kidney exchange and implementation in the United States of a new system for allocation of deceased donor kidneys granting waiting list priority to highly sensitized transplant candidates, those candidates with… read more here.
Keywords: posttransplantation; amr; active amr; antibody mediated ... See more keywords